Featured Research

from universities, journals, and other organizations

Medication Used To Stop Organ Rejection Found To Successfully Treat The Most Common, Chronic Skin Disease In Children

Date:
October 29, 1998
Source:
National Jewish Medical And Research Center
Summary:
In the first study of its kind in children, tacrolimus, used to fight organ rejection, has been found to combat atopic dermatitis in children. “We’ve had patients that after four days of treatment were already looking significantly better,” said Mark Boguniewicz, M.D., who treats children with atopic dermatitis at National Jewish.

DENVER-In the first study of its kind in children, tacrolimus, used to fight organ rejection, has been found to combat atopic dermatitis in children, according to research published recently in the Journal of Allergy and Clinical Immunology. “We’ve had patients that after four days of treatment were already looking significantly better,” said Mark Boguniewicz, M.D., who treats children with atopic dermatitis at National Jewish Medical and Research Center and is the study’s lead author.

Although ointments with high concentrations of corticosteroids may get similar results, they can have unacceptable side effects. “There would be concern about the effects to the skin and body, especially with more potent preparations,” he said.

“Unlike corticosteroids, tacrolimus doesn’t cause thinning of the skin, which can be permanent,” Dr. Boguniewicz said. “Some people have tissue paper thin skin and bruise easily from chronic corticosteroid use. The face is a special concern because it’s most susceptible to steroid side effects.”

Tacrolimus, a drug that can suppress the immune system when given intravenously, was used as a topical skin treatment in this clinical trial involving 180 children, ages 7-16 at 18 centers throughout the United States. The children had moderate-to-severe atopic dermatitis, which affected 5-30 percent of the body’s skin.

Children were supplied with one of three different concentrations of tacrolimus ointment. Improvement or clearing of the condition ranged from 67-70 percent of the children using the tacrolimus ointment, compared to 38 percent that had ointment with no medication.

In topical form the medication appears safe, according to the study, except for a minor burning sensation of the skin that disappears after about four days.

“What we see is that the medication works so quickly and heals the skin that it isn’t further absorbed,” Dr. Boguniewicz said. “That’s why there aren’t systemic side effects.”

The most common chronic skin disease of young children, atopic dermatitis affects about 10 percent of children in the United States. But it affects people of all ages. “It impacts significantly on their quality of life,” he said. “It’s a cause of school absenteeism and occupational disabilities, hampers social interaction and disrupts sleep.”

Atopic dermatitis, characterized by chronic skin inflammation, skin redness, areas of hard, rough skin and severe itching, is complicated by staph bacteria infections on the skin.

A year-long study of tacrolimus is underway at National Jewish. Tacrolimus should be available as a treatment for atopic dermatitis in about one year.

National Jewish Medical and Research Center is ranked as the best hospital in the United States for pulmonary disease treatment by U.S. News & World Report, 1998.

http://www.nationaljewish.org/pa


Story Source:

The above story is based on materials provided by National Jewish Medical And Research Center. Note: Materials may be edited for content and length.


Cite This Page:

National Jewish Medical And Research Center. "Medication Used To Stop Organ Rejection Found To Successfully Treat The Most Common, Chronic Skin Disease In Children." ScienceDaily. ScienceDaily, 29 October 1998. <www.sciencedaily.com/releases/1998/10/981028145841.htm>.
National Jewish Medical And Research Center. (1998, October 29). Medication Used To Stop Organ Rejection Found To Successfully Treat The Most Common, Chronic Skin Disease In Children. ScienceDaily. Retrieved September 3, 2014 from www.sciencedaily.com/releases/1998/10/981028145841.htm
National Jewish Medical And Research Center. "Medication Used To Stop Organ Rejection Found To Successfully Treat The Most Common, Chronic Skin Disease In Children." ScienceDaily. www.sciencedaily.com/releases/1998/10/981028145841.htm (accessed September 3, 2014).

Share This



More Health & Medicine News

Wednesday, September 3, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Snack Attack: Study Says Action Movies Make You Snack More

Snack Attack: Study Says Action Movies Make You Snack More

Newsy (Sep. 2, 2014) You're more likely to gain weight while watching action flicks than you are watching other types of programming, says a new study published in JAMA. Video provided by Newsy
Powered by NewsLook.com
U.N. Says Ebola Travel Restrictions Will Cause Food Shortage

U.N. Says Ebola Travel Restrictions Will Cause Food Shortage

Newsy (Sep. 2, 2014) The U.N. says the problem is two-fold — quarantine zones and travel restrictions are limiting the movement of both people and food. Video provided by Newsy
Powered by NewsLook.com
Doctors Fear They're Losing Battle Against Ebola

Doctors Fear They're Losing Battle Against Ebola

AP (Sep. 2, 2014) As a third American missionary is confirmed to have contracted Ebola in Liberia, doctors on the ground in West Africa fear they're losing the battle against the outbreak. (Sept. 2) Video provided by AP
Powered by NewsLook.com
Tech Giants Bet on 3D Headsets for Gaming, Healthcare

Tech Giants Bet on 3D Headsets for Gaming, Healthcare

AFP (Sep. 2, 2014) When Facebook acquired the virtual reality hardware developer Oculus VR in March for $2 billion, CEO Mark Zuckerberg hailed the firm's technology as "a new communication platform." Duration: 02:24 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins